Skip to main content
Videos

Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX

July 11, 2022

Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.

 

Contacts

von Mühlenen, Eva
Senior Advisor
Sommer, Josefine
合伙人律师

Related Resources

Related Blogs

Capabilities

Related Pages

Suggested News & Insights

A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026
活动
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026
活动
HHS Secretary Announces Intent to Extend HHS-OIG Exclusion Authority to CMS, Expanding the Administration’s Anti-Fraud CampaignSeptember 16, 2026
GoodLifeSci
FDA and SEC Announce Coordination on Scrutiny of Public DisclosuresSeptember 16, 2026
Food, Drug and Medical Device Update
Sidley Represents American Healthcare REIT in US$819 Million Common Stock OfferingSeptember 14, 2026
公告
Sidley Wins Seven Honors at the 2026 LMG Life Sciences Americas AwardsSeptember 11, 2026
荣誉